EarningsQ3 2024 Earnings Report

Novavax (NVAX) Q3 2024 Earnings Report

0 Followers

MX:NVAX Q3 2024 EPS Results

Actual EPS-$13.68

Consensus EPS-$14.24

Beat/MissBeat by +$0.56

One Year Ago EPS-$22.69

Actual Revenue$1.52B

Expected Revenue$1.33B

Beat/MissBeat by +$193.17M

YoY Revenue Growth-54.80%

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.23 / -	-22.506	―
Aug 06, 2026	2026 (Q2)	-6.84 / -5.76	11.163	-151.61% (-16.92)
May 06, 2026	2026 (Q1)	-4.36 / -1.08	52.754	-102.05% (-53.83)
Feb 26, 2026	2025 (Q4)	-8.73 / 1.98	-9.182	121.57% (+11.16)
Nov 06, 2025	2025 (Q3)	-21.53 / -22.51	-13.684	-64.47% (-8.82)
Aug 06, 2025	2025 (Q2)	0.14 / 11.16	17.825	-37.37% (-6.66)
May 08, 2025	2025 (Q1)	-7.62 / 52.75	-18.905	379.05% (+71.66)
Feb 27, 2025	2024 (Q4)	-9.25 / -9.18	-25.927	64.58% (+16.74)
Nov 12, 2024	2024 (Q3)	-14.24 / -13.68	-22.686	39.68% (+9.00)
Aug 08, 2024	2024 (Q2)	30.07 / 17.82	10.443	70.69% (+7.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed